Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.
IPC Indice de Precios Y Cotizaciones 50,542.11-402.47-0.79% ...